Paper359267
Malignant mesothelioma. Current status and future prospects.
Aisner J and 1 other. Chest, 1978. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Malignant mesothelioma. Current status and future prospects. Papers, record 359267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/359267
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesothelioma | Major topic |
| Pleural Neoplasms | Major topic |
| Air Pollutants, Occupational | |
| Animals | |
| Antineoplastic Agents | |
| Asbestos | |
| Carcinogens, Environmental | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Forecasting | |
| Humans | |
| Prognosis | |
| Radioisotopes | |
| Smoking | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15227158 | Recurrent malignant pleural mesothelioma: case report. | Tex Heart Inst J | 1983 | https://conductscience.org/library/papers/15227158 | PubMed |
| 7197593 | Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7197593 | PubMed |
| 6761970 | Diffuse malignant mesothelioma: a review. | West J Med | 1982 | https://conductscience.org/library/papers/6761970 | PubMed |
| 6426072 | Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. | Thorax | 1984 | https://conductscience.org/library/papers/6426072 | PubMed |
| 3395586 | Malignant pleural mesothelioma in a nuclear engineer. | Br J Ind Med | 1988 | https://conductscience.org/library/papers/3395586 | PubMed |
| 3210656 | Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985. | Klin Wochenschr | 1988 | https://conductscience.org/library/papers/3210656 | PubMed |
| 3192391 | Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study. | Invest New Drugs | 1988 | https://conductscience.org/library/papers/3192391 | PubMed |
| 1914074 | Chemotherapy in malignant mesothelioma: a review. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1914074 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/359267
GET https://conductscience.org/api/papers/v1/359267/authors